REN and Hyperkalemia: The potential benefits of renin–angiotensin–aldosterone system (RAAS) blockers in elderly patients must be weighed against the potential risks of acute kidney injury and hyperkalemia due to age-related reductions in serum renin and aldosterone levels.14